| 2601 |
|
TRANSFUSION MEDICINE - Identification of the Dombrock blood group glycoprotein as a polymorphic member of the ADP-ribosyltransferase gene family/
|
Gubin, A N
|
W.B. Saunders Co., etc.]
|
2000
|
|
|
|
| 2602 |
|
TRANSFUSION MEDICINE - Molecular identification of Knops blood group polymorphisms found in long homologous region D of complement receptor 1/
|
Moulds, J M
|
W.B. Saunders Co., etc.]
|
2001
|
|
|
|
| 2603 |
|
TRANSFUSION MEDICINE - o-Raffinose cross-linked hemoglobin improves the hemostatic defect associated with anemia and thrombocytopenia in rabbits/
|
Lee, D H
|
W.B. Saunders Co., etc.]
|
2001
|
|
|
|
| 2604 |
|
TRANSFUSION MEDICINE - Polyethylene glycol-coated red blood cells fail to bind glycophorin A - Specific antibodies and are impervious to invasion by the Plasmodium falciparum malaria parasite/
|
Blackall, D P
|
W.B. Saunders Co., etc.]
|
2001
|
|
|
|
| 2605 |
|
TRANSFUSION MEDICINE - The effect of leukocyte-reduction method on the amount of human cytomegalovirus in blood products: A comparison of apheresis and filtration methods/
|
Dumont, L J
|
W.B. Saunders Co., etc.]
|
2001
|
|
|
|
| 2606 |
|
Transfusion-transmitted cytomegalovirus infection after receipt of leukoreduced blood products/
|
Nichols, W. G
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|
| 2607 |
|
Transgenic delivery of VEGF to mouse skin leads to an inflammatory condition resembling human psoriasis/
|
Xia, Y.-P
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|
| 2608 |
|
Transgenic mice overexpressing erythropoietin adapt to excessive erythrocytosis by regulating blood viscosity/
|
Vogel, J
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|
| 2609 |
|
Transgenic sickle mice have vascular inflammation/
|
Belcher, J. D
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|
| 2610 |
|
Transient benefit only from increasing the imatinib dose in CML patients who do not achieve complete cytogenetic remissions on conventional doses/
|
Marin, D
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|
| 2611 |
|
Transient down-modulation of CD20 by rituximab in patients with chronic lymphoeytic leukemia/
|
Jilani, I
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|
| 2612 |
|
Transient expansion of Mac1^+Ly6-G^+Ly6-C^+ early myeloid cells with suppressor activity in spleens of murine radiation marrow chimeras: possible implications for the graft-versus-host and graft-versus-leukemia reactivity of donor lymphocyte infusions/
|
Billiau, A. D
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|
| 2613 |
|
TRANSPLANTATION - Administration of interleukin-7 after allogeneic bone marrow transplantation improves immune reconstitution without aggravating graft-versus-host disease/
|
Alpdogan, O
|
W.B. Saunders Co., etc.]
|
2001
|
|
|
|
| 2614 |
|
TRANSPLANTATION - Allogeneic chimerism with low-dose irradiation, antigen presensitization, and costimulator blockade in H-2 mismatched mice/
|
Quesenberry, P J
|
W.B. Saunders Co., etc.]
|
2001
|
|
|
|
| 2615 |
|
TRANSPLANTATION - Altered T-cell receptor + CD28-mediated signaling and blocked cell cycle progression in interleukin 10 and transforming growth factor-b-treated alloreactive T cells that do not induce graft-versus-host disease/
|
Boussiotis, V A
|
W.B. Saunders Co., etc.]
|
2001
|
|
|
|
| 2616 |
|
TRANSPLANTATION - Bone marrow transplantation from unrelated donors: The impact of mismatches with substitutions at position 116 of the human leukocyte antigen class I heavy chain/
|
Ferrara, G B
|
W.B. Saunders Co., etc.]
|
2001
|
|
|
|
| 2617 |
|
TRANSPLANTATION - CD34 expression by murine hematopoietic stem cells mobilized by granulocyte colony-stimulating factor/
|
Tajima, F
|
W.B. Saunders Co., etc.]
|
2000
|
|
|
|
| 2618 |
|
TRANSPLANTATION - Decreased immune functions of blood cells following mobilization with granulocyte colony-stimulating factor: Association with donor characteristics/
|
Joshi, S S
|
W.B. Saunders Co., etc.]
|
2001
|
|
|
|
| 2619 |
|
TRANSPLANTATION - Defective antifungal T-helper 1 (TH1) immunity in a murine model of allogeneic T-cell-depleted bone marrow transplantation and its restoration by treatment with TH2 cytokine antagonists/
|
Mencacci, A
|
W.B. Saunders Co., etc.]
|
2001
|
|
|
|
| 2620 |
|
TRANSPLANTATION - Differential use of Fas ligand and perforin cytotoxic pathways by donor T cells in graft-versus-host disease and graft-versus-leukemia effect/
|
Schmaltz, C
|
W.B. Saunders Co., etc.]
|
2001
|
|
|
|
Beutler, E
(7)
